Group 1 - The core viewpoint of the article highlights the performance of the Hong Kong Innovative Drug ETF managed by Penghua, which saw a slight increase in value but a significant reduction in shares over the recent trading period [1] - On September 29, the ETF's share price increased by 0.61%, with a trading volume of 88.4433 million yuan [1] - The ETF's total shares decreased by 3 million, bringing the latest total to 558 million shares, with a reduction of 15 million shares over the past 20 trading days [1] Group 2 - The latest net asset value of the ETF is calculated to be 550 million yuan [1] - The performance benchmark for the ETF is the National Index of Hong Kong Innovative Drugs, adjusted for exchange rates [1] - Since its inception on August 20, 2025, the ETF has recorded a return of -1.33%, while the return over the past month is 0.88% [1]
9月29日港股创新药ETF鹏华（159286）份额减少300.00万份
Xin Lang Cai Jing·2025-09-30 01:12